| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/26/2002 | CA2144514C Morphogen-induced liver regeneration |
| 03/26/2002 | CA2137551C A novel endothelial cell molecule mediating lymphocyte binding in man |
| 03/26/2002 | CA1341351C Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
| 03/21/2002 | WO2002023202A2 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 03/21/2002 | WO2002023195A2 Method for detecting clostridium botulinum neurotoxin serotypes a, b, e and f in a sample |
| 03/21/2002 | WO2002022871A2 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | WO2002022851A2 Novel tumor-associated marker |
| 03/21/2002 | WO2002022818A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 03/21/2002 | WO2002022809A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 03/21/2002 | WO2002022807A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | WO2002022806A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | WO2002022795A2 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | WO2002022782A2 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | WO2002022777A2 Cellular genes involved in oncogenesis, products of said genes and their diagnostic and therapeutic uses |
| 03/21/2002 | WO2002022687A2 Viral chemokine-tumur antigen fusion proteins |
| 03/21/2002 | WO2002022685A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/21/2002 | WO2002022684A2 Transporters and ion channels |
| 03/21/2002 | WO2002022682A1 Interferon-alpha induced gene |
| 03/21/2002 | WO2002022680A2 Site-specific, antibody-mediated activation of proapoptotic cytokine: amaice (antibody-mediated apoptosis inducing cytokine) |
| 03/21/2002 | WO2002022678A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | WO2002022664A2 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/21/2002 | WO2002022659A2 DISCRIMINATION BETWEEN GnRH-I AND GnRH-II |
| 03/21/2002 | WO2002022573A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | WO2002022212A2 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 03/21/2002 | WO2002022166A2 Tweak receptor agonists as anti-angiogenic agents |
| 03/21/2002 | WO2002022079A2 Methods of preparing immune globulin and uses thereof |
| 03/21/2002 | WO2002022077A2 Compositions and methods for inhibition of hiv-1 infection |
| 03/21/2002 | WO2002021996A2 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | WO2001098324A8 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 03/21/2002 | WO2001096388A8 Compositions and methods for the therapy and diagnosis of colon cancer |
| 03/21/2002 | WO2001094419A3 Method to induce the th1 immune response |
| 03/21/2002 | WO2001087982A3 Immunotoxin fusion proteins and means for expression thereof |
| 03/21/2002 | WO2001079484A3 Method for detecting iodized thyroglobulin in human serum after thyroid ablation |
| 03/21/2002 | WO2001077341A3 Mammalian heparanase |
| 03/21/2002 | WO2001072841A3 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001072840A3 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 03/21/2002 | WO2001068861A3 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IgE ANTIBODY AND USES THEREOF |
| 03/21/2002 | WO2001068859A3 Il-17 receptor like molecules and uses thereof |
| 03/21/2002 | WO2001068123A3 Monocyte chemoattractant activity of galectin-3 |
| 03/21/2002 | WO2001060991A3 Human kinases |
| 03/21/2002 | WO2001051638A3 Drug metabolizing enzymes |
| 03/21/2002 | WO2001040465A3 Compositions and methods for the treatment of immune related diseases |
| 03/21/2002 | WO2001037779A3 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 03/21/2002 | WO2001032712A3 Antibody diversity generation |
| 03/21/2002 | WO2000063444A3 Method for detecting hepatitis c virus with hybridomas |
| 03/21/2002 | US20020035325 Method for detecting lymphoid tissue in tumor progression |
| 03/21/2002 | US20020035241 Process for the separation and/or isolation of plasma proteins by means of annular chromatography |
| 03/21/2002 | US20020035240 Novel mammalian cell cycle protein |
| 03/21/2002 | US20020035078 Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity |
| 03/21/2002 | US20020035062 Process for the preparation of a protein solution |
| 03/21/2002 | US20020035058 Isopentenyl pyrophosphate isomerase (IPI) and/or prenyl transferase inhibitors |
| 03/21/2002 | US20020034809 Process for producing a plasma protein-containing medicament |
| 03/21/2002 | US20020034806 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 03/21/2002 | US20020034803 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/21/2002 | US20020034800 Preferential bone marrow polypeptides; for generation of erythrocytes; for healing fractured bones |
| 03/21/2002 | US20020034787 Nucleotide sequences coding polypeptides for use in treatment of wounds, burns, ulcers, nervous system disorders and tumors |
| 03/21/2002 | US20020034786 Nucleotide sequences coding G protein coupled receptor; for use in the diagnosis and treatment of defects in signal transduction |
| 03/21/2002 | US20020034779 Novel argS |
| 03/21/2002 | US20020034778 Peptide; for use in drug screening; for use as a diagnostic tool; for use in the treatment of nervous system disorders |
| 03/21/2002 | US20020034777 Modulator of use in the diagnosis, prevention and treatment of inflammation, cancer and nervous system disorders; hypotensive agent |
| 03/21/2002 | US20020034769 Novel glycolipid complexes and their uses |
| 03/21/2002 | US20020034765 Method for reducing the immunogenicity of antibody variable domains |
| 03/21/2002 | US20020034763 Immunoglobulin that binds to preferential cell surface protein; for use in detection of preferential microorganisms |
| 03/21/2002 | US20020034758 Novel human genes and gene expressions products: II |
| 03/21/2002 | US20020034743 Nucleotide sequences coding protein for use in the detection, diagnosis, prevention and treatment of human cancers |
| 03/21/2002 | US20020034740 Reagents and methods useful for detecting diseases of the breast |
| 03/21/2002 | US20020034736 Nucleotide sequences coding modulators for use in therapy against tumors, retinopathy, perfusion injuries, fibrosis, artherosclerosis, angiogenesis, inflammation, and restenosis; antiischemic and antitumor agents |
| 03/21/2002 | US20020034733 Novel methods for displaying (poly) pepti des/proteins on bacteriophage particles via disulfide bonds |
| 03/21/2002 | US20020034509 Methods and compositions for ameliorating the symptoms of sepsis |
| 03/21/2002 | US20020034508 Binding antibody to epitopes |
| 03/21/2002 | US20020034507 Inhibitor of lymphocyte activation |
| 03/21/2002 | CA2452023A1 Method for detecting clostridium botulinum neurotoxin serotypes a, b, e and f in a sample |
| 03/21/2002 | CA2422828A1 Novel tumor-associated marker |
| 03/21/2002 | CA2422586A1 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies |
| 03/21/2002 | CA2422497A1 Transporters and ion channels |
| 03/21/2002 | CA2422426A1 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | CA2422278A1 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 03/21/2002 | CA2422275A1 Compositions and methods for inhibition of hiv-1 infection |
| 03/21/2002 | CA2422163A1 Isolated human kinase proteins, nucleic acid molecules and uses thereof |
| 03/21/2002 | CA2422152A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/21/2002 | CA2422095A1 Tweak receptor agonists as anti-angiogenic agents |
| 03/21/2002 | CA2422080A1 Method to identify therapeutic antibody targets associated with a therapeutic response |
| 03/21/2002 | CA2422076A1 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 03/21/2002 | CA2422053A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | CA2421952A1 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 03/21/2002 | CA2421751A1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/21/2002 | CA2421234A1 Interferon-alpha induced gene |
| 03/21/2002 | CA2420459A1 Novel dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | CA2419894A1 Process for high throughput screening of cpg-based immuno-agonist/antagonist |
| 03/21/2002 | CA2391407A1 Antigenic proteins of shrimp white spot syndrome virus and uses thereof |
| 03/20/2002 | EP1188832A1 A delivery method for the tumor specific apoptosis inducing activity of apoptin |
| 03/20/2002 | EP1188824A2 Human foam cells and methods for preparing them, monoclonal antibodies to said foam cells and their pharmaceutical and diagnostic use |
| 03/20/2002 | EP1188771A1 Libraries of human heavy chain variable fragments in a functional format |
| 03/20/2002 | EP1188766A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 03/20/2002 | EP1187931A1 49 human secreted proteins |
| 03/20/2002 | EP1187918A1 Tek antagonists |
| 03/20/2002 | EP1187917A1 Cd44 splice variant associated with rheumatoid arthritis |
| 03/20/2002 | EP1187916A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 03/20/2002 | EP1187915A2 Compounds for therapy and diagnosis of lung cancer and methods for their use |
| 03/20/2002 | EP1187908A1 42 human secreted proteins |